Literature DB >> 11470488

Analysis of TGF-beta type I receptor for mutations and polymorphisms in head and neck cancers.

T J Knobloch1, M A Lynch, H Song, V L DeGroff, B C Casto, E M Adams, K Y Alam, J C Lang, D E Schuller, C M Weghorst.   

Abstract

Transforming growth factor-beta receptor (TbetaR)-dependent signals are critical for cell growth and differentiation and are often disrupted during tumorigenesis. The entire coding region of TbetaR-I and flanking intron sequences from 30 head and neck carcinomas were examined for alterations using "Cold" SSCP and direct sequencing. No somatic point mutations were found in the TbetaR-I gene. In contrast, 14 polymorphic sequence changes were detected in TbetaR-I in 13 (43%) of the samples, including eight (27%) nucleotide alterations identified as polymorphisms in an exon-1 (GCG)(9) microsatellite repeat, a previously reported tumor susceptibility allele. A nine base pair deletion was found in 23% of the samples including five heterozygous and two homozygous deletions as well as single homozygous 12bp deletion. Additionally, six heterozygous polymorphisms in intronic sequences were determined, including one heterozygous C/A genotype at the +82 nucleotide position of the intron-5 intervening sequence (IVS), and five heterozygous G/A genotypes within intron-7 at the +24 nucleotide position. Exon-1 polymorphisms in the (GCG)(9) microsatellite region of the TbetaR-I gene and their association with head/neck cancers, suggest that development of these cancers may be a direct consequence of loss of responsiveness to TGF-beta mediated growth inhibition.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11470488     DOI: 10.1016/s0027-5107(01)00157-9

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  4 in total

1.  Analysis of transforming growth factor β receptor expression and signaling in higher grade meningiomas.

Authors:  Mahlon D Johnson; Aubie K Shaw; Mary J O'Connell; Fraser J Sim; Harold L Moses
Journal:  J Neurooncol       Date:  2010-09-19       Impact factor: 4.130

2.  Aberrant methylation inactivates transforming growth factor Beta receptor I in head and neck squamous cell carcinoma.

Authors:  Teresita Muñoz-Antonia; Mariclara Torrellas-Ruiz; Jonathan Clavell; Linda A Mathews; Carlos A Muro-Cacho; Adriana Báez
Journal:  Int J Otolaryngol       Date:  2009-06-14

3.  Progressive tumor formation in mice with conditional deletion of TGF-beta signaling in head and neck epithelia is associated with activation of the PI3K/Akt pathway.

Authors:  Yansong Bian; Anita Terse; Juan Du; Bradford Hall; Alfredo Molinolo; Pin Zhang; Wanjun Chen; Kathleen C Flanders; J Silvio Gutkind; Lalage M Wakefield; Ashok B Kulkarni
Journal:  Cancer Res       Date:  2009-07-07       Impact factor: 12.701

4.  Disruption of transforming growth factor beta-Smad signaling pathway in head and neck squamous cell carcinoma as evidenced by mutations of SMAD2 and SMAD4.

Authors:  Wanglong Qiu; Frank Schönleben; Xiaojun Li; Gloria H Su
Journal:  Cancer Lett       Date:  2006-02-14       Impact factor: 8.679

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.